Abonnement à la biblothèque: Guest
Critical Reviews™ in Neurobiology

Publication de 3  numéros par an

ISSN Imprimer: 0892-0915

ISSN En ligne: 2375-0014

SJR: 0.121

Neuroprotective and Neurotrophic Actions of the Mood Stabilizer Lithium: Can It Be Used to Treat Neurodegenerative Diseases?

Volume 16, Numéro 1&2, 2004, pp. 83-90
DOI: 10.1615/CritRevNeurobiol.v16.i12.90
Get accessGet access

RÉSUMÉ

The mood stabilizing drug lithium has emerged as a robust neuroprotective agent in preventing apoptosis of neurons. Long-term treatment with lithium effectively protects primary cultures of rat brain neurons from glutamate-induced, NMDA receptor-mediated excitotoxicity. This neuroprotection is accompanied by an inhibition of NMDA-receptor—mediated calcium influx, upregulation of anti-apoptotic Bcl-2, downregulation of pro-apoptotic p53 and Bax, and activation of cell survival factors. Lithium treatment antagonizes glutamate-induced activation of c-Jun-N-terminal kinase (JNK), p38 kinase, and AP-1 binding, which has a major role in cytotoxicity, and suppresses glutamate-induced loss of phosphorylated cAMP responsive element binding protein (CREB). Lithium also induces the expression of brain-derived neurotrophic factor (BDNF) and subsequent activation TrkB, the receptor for BDNF, in cortical neurons. The activation of BDNF/TrkB signaling is essential for the neuroprotective effects of this drug. In addition, lithium stimulates the proliferation of neuroblasts in primary cultures of CNS neurons.
Lithium also shows neuroprotective effects in rodent models of diseases. In a rat model of stroke, post-insult treatment with lithium or valproate, another mood stabilizer, at therapeutic doses markedly reduces brain infarction and neurological deficits. This neuroprotection is associated with suppression of caspase-3 activation and induction of chaperone proteins such as heat shock protein 70. In a rat model of Huntington's disease (HD) in which an excitotoxin is unilaterally infused into the striatum, both long- and short-term pretreatment with lithium reduces DNA damage, caspase-3 activation, and loss of striatal neurons. This neuroprotection is associated with upregulation of Bcl-2. Lithium also induces cell proliferation near the injury site with a concomitant loss of proliferating cells in the subventricular zone. Some of these proliferating cells display neuronal or astroglial phenotypes. These results corroborate our findings obtained in primary neuronal cultures. The neuroprotective and neurotrophic actions of lithium have profound clinical implications. In addition to its present use in bipolar patients, lithium could be used to treat acute brain injuries such as stroke and chronic progressive neurodegenerative diseases.

CITÉ PAR
  1. Passmore Michael J, Gardner David M, Polak Yvette, Rabheru Kiran, Alternatives to Atypical Antipsychotics for the Management of Dementia-Related Agitation, Drugs & Aging, 25, 5, 2008. Crossref

  2. Kishore Bellamkonda K., Nelson Raoul D., Miller R. Lance, Carlson Noel G., Kohan Donald E., P2Y2 receptors and water transport in the kidney, Purinergic Signalling, 5, 4, 2009. Crossref

  3. Machado-Vieira Rodrigo, Zarate Carlos A., Manji Husseini K., Emerging novel treatments for severe mood disorders involving cellular plasticity cascades, Current Psychosis & Therapeutics Reports, 4, 4, 2006. Crossref

  4. Schloesser Robert J, Huang Jian, Klein Peter S, Manji Husseini K, Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder, Neuropsychopharmacology, 33, 1, 2008. Crossref

  5. Zarrindast Mohammad-Reza, Shendy Manizheh Mardaneh, Ahmadi Shamseddin, Nitric oxide modulates state dependency induced by lithium in an inhibitory avoidance task in mice, Behavioural Pharmacology, 18, 4, 2007. Crossref

  6. Mann Liad, Heldman Eliahu, Bersudsky Yuly, Vatner Stephen F, Ishikawa Yoshihiro, Almog Orna, Belmaker Robert H, Agam Galila, Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect, Bipolar Disorders, 11, 8, 2009. Crossref

  7. Schindowski K., Belarbi K., Buée L., Neurotrophic factors in Alzheimer’s disease: role of axonal transport, Genes, Brain and Behavior, 7, 2008. Crossref

  8. Yeste M., Alvira D., Verdaguer E., Tajes M., Folch J., Rimbau V., Pallàs M., Camins A., Evaluation of acute antiapoptotic effects of Li+ in neuronal cell cultures, Journal of Neural Transmission, 114, 4, 2007. Crossref

  9. Fountoulakis Konstantinos N., Vieta Eduard, Bouras Constantin, Notaridis Grigorios, Giannakopoulos Panteleimon, Kaprinis George, Akiskal Hagop, A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?, The International Journal of Neuropsychopharmacology, 11, 02, 2008. Crossref

  10. Chen Guang, Manji Husseini K, The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers, Current Opinion in Psychiatry, 19, 3, 2006. Crossref

  11. Liu Ko-Jiunn, Lee Yueh-Lun, Yang Yi-Yuan, Shih Neng-Yao, Ho Chia-Chen, Wu Yu-Chen, Huang Tze-Sing, Huang Ming-Chyi, Liu Hsing-Cheng, Shen Winston W, Leu Sy-Jye, Modulation of the development of human monocyte-derived dendritic cells by lithium chloride, Journal of Cellular Physiology, 226, 2, 2011. Crossref

  12. M. Ali Awatef, Reproductive System Toxicity in Male Swiss Mice under Supplementation of Camcolit, International Journal of Zoological Research, 4, 2, 2008. Crossref

  13. Hammonds Michael D., Shim Seong S., Effects of 4-week Treatment with Lithium and Olanzapine on Levels of Brain-derived Neurotrophic Factor, B-Cell CLL/Lymphoma 2 and Phosphorylated Cyclic Adenosine Monophosphate Response Element-binding Protein in the Sub-regions of the Hippocampus, Basic & Clinical Pharmacology & Toxicology, 105, 2, 2009. Crossref

  14. Yucel Kaan, Taylor Valerie H, McKinnon Margaret C, MacDonald Kathryn, Alda Martin, Young L Trevor, MacQueen Glenda M, Bilateral Hippocampal Volume Increase in Patients with Bipolar Disorder and Short-term Lithium Treatment, Neuropsychopharmacology, 33, 2, 2008. Crossref

  15. Pasquali Livia, Busceti Carla L., Fulceri Federica, Paparelli Antonio, Fornai Francesco, Intracellular pathways underlying the effects of lithium, Behavioural Pharmacology, 21, 5-6, 2010. Crossref

  16. Martinowich Keri, Schloesser Robert J., Manji Husseini K., Bipolar disorder: from genes to behavior pathways, Journal of Clinical Investigation, 119, 4, 2009. Crossref

  17. Assadi Mitra, Janson Christopher, Wang Dah-Jyuu, Goldfarb Olga, Suri Neeti, Bilaniuk Larissa, Leone Paola, Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease, European Journal of Paediatric Neurology, 14, 4, 2010. Crossref

  18. O’Donnell Kelley C., Gould Todd D., The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics, Neuroscience & Biobehavioral Reviews, 31, 6, 2007. Crossref

  19. Rapoport Stanley I., Basselin Mireille, Kim Hyung-Wook, Rao Jagadeesh S., Bipolar disorder and mechanisms of action of mood stabilizers, Brain Research Reviews, 61, 2, 2009. Crossref

  20. Kasuya J., Kaas G.A., Kitamoto T., A putative amino acid transporter of the solute carrier 6 family is upregulated by lithium and is required for resistance to lithium toxicity in Drosophila, Neuroscience, 163, 3, 2009. Crossref

  21. Carlson Paul J., Singh Jaskaran B., Zarate Carlos A., Drevets Wayne C., Manji Husseini K., Neural circuitry and neuroplasticity in mood disorders: Insights for novel therapeutic targets, NeuroRX, 3, 1, 2006. Crossref

  22. References, in Calcium Binding Proteins, 2010. Crossref

  23. Yong Yue, Ding Hanqing, Fan Zhiqin, Luo Jia, Ke Zun-Ji, Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson’s Disease, Neurochemical Research, 36, 3, 2011. Crossref

  24. Kim Hyung-Wook, Rapoport Stanley I., Rao Jagadeesh S., Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients, Neurobiology of Disease, 37, 3, 2010. Crossref

  25. Plant Kathryn E., Anderson Elizabeth, Simecek Nicole, Brown Richard, Forster Sam, Spinks Jenny, Toms Nick, Gibson G. Gordon, Lyon Jon, Plant Nick, The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1, Toxicology and Applied Pharmacology, 235, 1, 2009. Crossref

  26. Zarrindast Mohammad Reza, Misaghi Sara, Ahmadi Shamseddin, The dopaminergic system plays a role in the effect of lithium on inhibitory avoidance memory in mice, European Journal of Pharmacology, 590, 1-3, 2008. Crossref

  27. Kasuya Junko, Kaas Garrett, Kitamoto Toshihiro, Effects of lithium chloride on the gene expression profiles in Drosophila heads, Neuroscience Research, 64, 4, 2009. Crossref

  28. Krasnova Irina N., Cadet Jean Lud, Methamphetamine toxicity and messengers of death, Brain Research Reviews, 60, 2, 2009. Crossref

  29. Huang Hui-Chuan, O’Brien W. Timothy, Klein Peter S., Targeting glycogen synthase kinase-3 in Alzheimer's disease, Drug Discovery Today: Therapeutic Strategies, 3, 4, 2006. Crossref

  30. Ishii Takao, Hashimoto Eri, Ukai Wataru, Tateno Masaru, Yoshinaga Toshihiro, Saito Satoshi, Sohma Hitoshi, Saito Toshikazu, Lithium-induced suppression of transcription repressor NRSF/REST: Effects on the dysfunction of neuronal differentiation by ethanol, European Journal of Pharmacology, 593, 1-3, 2008. Crossref

  31. Tsaltas Eleftheria, Kontis Dimitrios, Boulougouris Vasileios, Papakosta Vasiliki-Maria, Giannou Haralambos, Poulopoulou Cornelia, Soldatos Constantine, Enhancing effects of chronic lithium on memory in the rat, Behavioural Brain Research, 177, 1, 2007. Crossref

  32. Ghasemi Abbas, Saberi Mohammad, Ghasemi Mehdi, Shafaroodi Hamed, Moezi Leila, Bahremand Arash, Montaser-Kouhsari Laleh, Ziai Pouya, Dehpour Ahmad Reza, Administration of lithium and magnesium chloride inhibited tolerance to the anticonvulsant effect of morphine on pentylenetetrazole-induced seizures in mice, Epilepsy & Behavior, 19, 4, 2010. Crossref

  33. Bazinet Richard P., Rao Jagadeesh S., Chang Lisa, Rapoport Stanley I., Lee Ho-Joo, Chronic Carbamazepine Decreases the Incorporation Rate and Turnover of Arachidonic Acid but Not Docosahexaenoic Acid in Brain Phospholipids of the Unanesthetized Rat: Relevance to Bipolar Disorder, Biological Psychiatry, 59, 5, 2006. Crossref

  34. Chiu Chi-Tso, Chuang De-Maw, Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders, Pharmacology & Therapeutics, 128, 2, 2010. Crossref

  35. Yulug Burak, Yildiz Aysegül, Hüdaoglu Orkide, Kilic Erdinc, Cam Ertugrul, Schäbitz Wolf Rüdiger, Olanzapine attenuates brain damage after focal cerebral ischemia in vivo, Brain Research Bulletin, 71, 1-3, 2006. Crossref

  36. Banafshe Hamid R., Mesdaghinia Azam, Arani Meysam Noorani, Ramezani Mehdi Honarkar, Heydari Azhdar, Hamidi Gholam A., Lithium attenuates pain-related behavior in a rat model of neuropathic pain: Possible involvement of opioid system, Pharmacology Biochemistry and Behavior, 100, 3, 2012. Crossref

  37. Cutler Sarah M., VanLandingham Jacob W., Stein Donald G., Tapered progesterone withdrawal promotes long-term recovery following brain trauma, Experimental Neurology, 200, 2, 2006. Crossref

  38. Liang Min-Huei, Wendland Jens R., Chuang De-Maw, Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling, Molecular and Cellular Neuroscience, 37, 3, 2008. Crossref

  39. Wei Han-Ting, Lai Ya-Wen, Chen Mu-Hong, Chen Ying-Sheue, Oral-paliperidone-induced tardive dyskinesia: a case report, General Hospital Psychiatry, 34, 5, 2012. Crossref

  40. Andreazza Ana Cristina, Noronha Frey Benicio, Erdtmann Bernardo, Salvador Mirian, Rombaldi Fernanda, Santin Aida, Gonçalves Carlos Alberto, Kapczinski Flavio, DNA damage in bipolar disorder, Psychiatry Research, 153, 1, 2007. Crossref

  41. Zhong Jin, Yao Weiguo, Lee Weihua, Cesium chloride protects cerebellar granule neurons from apoptosis induced by low potassium, International Journal of Developmental Neuroscience, 25, 6, 2007. Crossref

  42. Alexander Jeanne Leventhal, Richardson Gregg, Grypma Lydia, Hunkeler Enid M, Collaborative depression care, screening, diagnosis and specificity of depression treatments in the primary care setting, Expert Review of Neurotherapeutics, 7, sup1, 2007. Crossref

  43. Wang Zhi-fei, Fessler Emily Bame, Chuang De-Maw, Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models, Acta Pharmacologica Sinica, 32, 12, 2011. Crossref

  44. Gould Todd D., Einat Haim, Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement, Neuroscience & Biobehavioral Reviews, 31, 6, 2007. Crossref

  45. Zhong Jin, Yang Xianlin, Yao Weiguo, Lee Weihua, Lithium protects ethanol-induced neuronal apoptosis, Biochemical and Biophysical Research Communications, 350, 4, 2006. Crossref

  46. Hashimoto Kenji, Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions, Psychiatry and Clinical Neurosciences, 64, 4, 2010. Crossref

  47. Yulug Burak, Yildiz Aysegül, Güzel Orkide, Kilic Erdinc, Schäbitz Wolf Rüdiger, Kilic Ertugrul, Risperidone attenuates brain damage after focal cerebral ischemia in vivo, Brain Research Bulletin, 69, 6, 2006. Crossref

  48. Nciri R., Allagui M.S., Vincent C., Murat J.C., Croute F., Feki A. El, Chronic lithium administration triggers an over-expression of GRP94 stress protein isoforms in mouse liver, Food and Chemical Toxicology, 48, 6, 2010. Crossref

  49. Andreazza Ana Cristina, Cassini Carina, Rosa Adriane Ribeiro, Leite Marina Concli, de Almeida Lucia M.V., Nardin Patrı´cia, Cunha Angelo B.N., Ceresér Keila Maria, Santin Aida, Gottfried Carmem, Salvador Mirian, Kapczinski Flavio, Gonçalves Carlos Alberto, Serum S100B and antioxidant enzymes in bipolar patients, Journal of Psychiatric Research, 41, 6, 2007. Crossref

  50. Pulido Jose E., Pulido Jose S., Erie Jay C., Arroyo Jorge, Bertram Kurt, Lu Miao-Jen, Shippy Scott A., A Role for Excitatory Amino Acids in Diabetic Eye Disease, Experimental Diabetes Research, 2007, 2007. Crossref

  51. Alexandrova Margarita L., Bochev Petyo G., Oxidative stress during the chronic phase after stroke, Free Radical Biology and Medicine, 39, 3, 2005. Crossref

  52. Xu Xi-Hui, Zhang Hui-Lin, Han Rong, Gu Zhen-Lun, Qin Zheng-Hong, Enhancement of neuroprotection and heat shock protein induction by combined prostaglandin A1 and lithium in rodent models of focal ischemia, Brain Research, 1102, 1, 2006. Crossref

  53. Rao J S, Keleshian V L, Klein S, Rapoport S I, Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients, Translational Psychiatry, 2, 7, 2012. Crossref

  54. Sadrian B., Subbanna S., Wilson D.A., Basavarajappa B.S., Saito M., Lithium prevents long-term neural and behavioral pathology induced by early alcohol exposure, Neuroscience, 206, 2012. Crossref

  55. Shim Sehwan, Kim Sokho, Kwon Young-Bae, Kwon Jungkee, Protection by [6]-shogaol against lipopolysaccharide-induced toxicity in murine astrocytes is related to production of brain-derived neurotrophic factor, Food and Chemical Toxicology, 50, 3-4, 2012. Crossref

  56. Nciri Riadh, Desmoulin Frank, Allagui Mohamed Saleh, Murat Jean-Claude, Feki Abdelfattah El, Vincent Christian, Croute Françoise, Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress, International Journal of Neuropsychopharmacology, 16, 2, 2013. Crossref

  57. Janson Christopher G., Assadi Mitra, Francis Jeremy, Bilaniuk Larissa, Shera David, Leone Paola, Lithium Citrate for Canavan Disease, Pediatric Neurology, 33, 4, 2005. Crossref

  58. Zhang Lei, Chen Xiaoyun, Feng Wei, Liang Hui, Cui Yonghua, Xu Shiqing, Che Yi, Enhancing Effects of Chronic Lithium Treatment on Detour Learning in Chicks, Biological Trace Element Research, 148, 1, 2012. Crossref

  59. Alexandrova Margarita L., Bochev Petyo G., Oxidative Stress in Stroke, in Oxidative Stress and Neurodegenerative Disorders, 2007. Crossref

  60. Li Xin‐Min, Xu Haiyun, Evidence for Neuroprotective Effects of Antipsychotic Drugs: Implications for the Pathophysiology and Treatment of Schizophrenia, in The Pharmacology of Neurogenesis and Neuroenhancement, 77, 2007. Crossref

  61. Soczynska Joanna K., Mansur Rodrigo B., Brietzke Elisa, Swardfager Walter, Kennedy Sidney H., Woldeyohannes Hanna O., Powell Alissa M., Manierka Marena S., McIntyre Roger S., Novel therapeutic targets in depression: Minocycline as a candidate treatment, Behavioural Brain Research, 235, 2, 2012. Crossref

  62. Castro Adalberto A., Ghisoni Karina, Latini Alexandra, Quevedo João, Tasca Carla I., Prediger Rui D.S., Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease, Behavioural Brain Research, 229, 1, 2012. Crossref

  63. Brietzke Elisa, Mansur Rodrigo B., Zugman Andre, Carvalho André F., Macêdo Danielle S., Cha Danielle S., Abílio Vanessa C., McIntyre Roger S., Is there a role for curcumin in the treatment of bipolar disorder?, Medical Hypotheses, 80, 5, 2013. Crossref

  64. Pryor Kane O., Storer Kingsley P., Drugs for Neuropsychiatric Disorders, in Pharmacology and Physiology for Anesthesia, 2013. Crossref

  65. Abu-Baker A, Laganiere J, Gaudet R, Rochefort D, Brais B, Neri C, Dion P A, Rouleau G A, Lithium chloride attenuates cell death in oculopharyngeal muscular dystrophy by perturbing Wnt/β-catenin pathway, Cell Death & Disease, 4, 10, 2013. Crossref

  66. Kim Sokho, Kwon Jungkee, [6]-Shogaol Attenuates Neuronal Apoptosis in Hydrogen Peroxide-Treated Astrocytes Through the Up-Regulation of Neurotrophic Factors, Phytotherapy Research, 27, 12, 2013. Crossref

  67. Freitas Andiara E., Bettio Luis E.B., Neis Vivian B., Moretti Morgana, Ribeiro Camille M., Lopes Mark W., Leal Rodrigo B., Rodrigues Ana Lúcia S., Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice, Journal of Psychiatric Research, 58, 2014. Crossref

  68. Croce Nicoletta, Bernardini Sergio, Caltagirone Carlo, Angelucci Francesco, Lithium/Valproic Acid Combination and l-Glutamate Induce Similar Pattern of Changes in the Expression of miR-30a-5p in SH-SY5Y Neuroblastoma Cells, NeuroMolecular Medicine, 16, 4, 2014. Crossref

  69. Fan Mingyue, Song Chunfeng, Wang Tianjun, Li Ling, Dong Yanhong, Jin Wei, LU Peiyuan, Protective effects of lithium chloride treatment on repeated cerebral ischemia–reperfusion injury in mice, Neurological Sciences, 36, 2, 2015. Crossref

  70. Honarmand Amir Reza, Pourtabatabaei Nasim, Rahimi Nastaran, Dehpour Ahmad Reza, Javadi-Paydar Mehrak, Suppression of memory acquisition following co-administration of lithium and atorvastatin through nitric oxide pathway in mice, Pharmacology Biochemistry and Behavior, 122, 2014. Crossref

  71. Nciri Riadh, Boujbiha Mohamed Ali, Jbahi Samira, Allagui Mohamed Salah, Elfeki Abdelfattah, Vincent Christian, Croute Françoise, Cytoskeleton involvement in lithium-induced SH-SY5Y neuritogenesis and the role of glycogen synthase kinase 3β, Aging Clinical and Experimental Research, 27, 3, 2015. Crossref

  72. Meffre D., Massaad C., Grenier J., Lithium chloride stimulates PLP and MBP expression in oligodendrocytes via Wnt/β-catenin and Akt/CREB pathways, Neuroscience, 284, 2015. Crossref

  73. Cai Junying, Hua Fuzhou, Yuan Linhui, Tang Wei, Lu Jun, Yu Shuchun, Wang Xifeng, Hu Yanhui, Potential Therapeutic Effects of Neurotrophins for Acute and Chronic Neurological Diseases, BioMed Research International, 2014, 2014. Crossref

  74. Kishore B. K., Carlson N. G., Ecelbarger C. M., Kohan D. E., Müller C. E., Nelson R. D., Peti-Peterdi J., Zhang Y., Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus, Acta Physiologica, 214, 2, 2015. Crossref

  75. Mury Fábio B., da Silva Weber C., Barbosa Nádia R., Mendes Camila T., Bonini Juliana S., Sarkis Jorge Eduardo Souza, Cammarota Martin, Izquierdo Ivan, Gattaz Wagner F., Dias-Neto Emmanuel, Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer’s disease, European Archives of Psychiatry and Clinical Neuroscience, 266, 7, 2016. Crossref

  76. Young Chainllie, Straiko Megan M.W., Johnson Stephen A., Creeley Catherine, Olney John W., Ethanol causes and lithium prevents neuroapoptosis and suppression of pERK in the infant mouse brain, Neurobiology of Disease, 31, 3, 2008. Crossref

  77. Chew Li-Jin, DeBoy Cynthia A., Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology, Neuropharmacology, 110, 2016. Crossref

  78. Gibbons Claire E., Maldonado-Pérez David, Shah Amish N., Riccardi Daniela, Ward Donald T., Calcium-sensing receptor antagonism or lithium treatment ameliorates aminoglycoside-induced cell death in renal epithelial cells, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1782, 3, 2008. Crossref

  79. Motaghinejad Majid, Seyedjavadein Zeinab, Motevalian Manijeh, Asadi Majid, The neuroprotective effect of lithium against high dose methylphenidate: Possible role of BDNF, NeuroToxicology, 56, 2016. Crossref

  80. Frazier Elisabeth A., Bipolar Disorder, in Encyclopedia of Adolescence, 2016. Crossref

  81. da Silva Fiorin Fernando, de Oliveira Ferreira Ana P., Ribeiro Leandro R., Silva Luiz F.A., de Castro Mauro R.T., da Silva Luís R.H., da Silveira Mauro E.P., Zemolin Ana P.P., Dobrachinski Fernando, Marchesan de Oliveira Sara, Franco Jeferson L., Soares Félix A., Furian Ana F., Oliveira Mauro S., Fighera Michele R., Freire Royes Luiz F., The Impact of Previous Physical Training on Redox Signaling after Traumatic Brain Injury in Rats: A Behavioral and Neurochemical Approach, Journal of Neurotrauma, 33, 14, 2016. Crossref

  82. Wu Ming-Mei, Zhu Ting-Ting, Wang Peng, Kuang Fang, Hao Ding-Jun, You Si-Wei, Li Yao-Yu, Dose-Dependent Protective Effect of Lithium Chloride on Retinal Ganglion Cells Is Interrelated with an Upregulated Intraretinal BDNF after Optic Nerve Transection in Adult Rats, International Journal of Molecular Sciences, 15, 8, 2014. Crossref

  83. Gao Yonglin, Lei Zhenmin, Lu Chengliang, Roisen Fred J., El-Mallakh Rif S., Effect of ionic stress on apoptosis and the expression of TRPM2 in human olfactory neuroepithelial-derived progenitors, The World Journal of Biological Psychiatry, 11, 8, 2010. Crossref

  84. Kokiko Olga N., Hamm Robert J., A review of pharmacological treatments used in experimental models of traumatic brain injury, Brain Injury, 21, 3, 2007. Crossref

  85. Zung S, Souza-Duran F L, Soeiro-de-Souza M G, Uchida R, Bottino C M, Busatto G F, Vallada H, The influence of lithium on hippocampal volume in elderly bipolar patients: a study using voxel-based morphometry, Translational Psychiatry, 6, 6, 2016. Crossref

  86. Rezayat M., Niasari H., Ahmadi S., Parsaei L., Zarrindast MR, N-methyl-D-aspartate receptors are involved in lithium-induced state-dependent learning in mice, Journal of Psychopharmacology, 24, 6, 2010. Crossref

  87. Zarrindast M-R., Lahmi A., Ahamadi S., Possible involvement of μ-opioid receptors in effect of lithium on inhibitory avoidance response in mice, Journal of Psychopharmacology, 22, 8, 2008. Crossref

  88. Zhang Yue, Nelson Raoul D., Carlson Noel G., Kamerath Craig D., Kohan Donald E., Kishore Bellamkonda K., Potential role of purinergic signaling in lithium-induced nephrogenic diabetes insipidus, American Journal of Physiology-Renal Physiology, 296, 5, 2009. Crossref

  89. Kotlyarova A. A., Letyagin A. Yu., Popova T. V., Rachkovskaya L. N., Tolstikova T. G., Preclinical investigation of the pharmacokinetic of a novel prolonged release dosage form of lithium citrate, 2017 International Multi-Conference on Engineering, Computer and Information Sciences (SIBIRCON), 2017. Crossref

  90. Nicolay JP, Gatz S., Lang F., Lang UE, Lithium-induced suicidal erythrocyte death, Journal of Psychopharmacology, 24, 10, 2010. Crossref

  91. Croce Nicoletta, Mathé Aleksander A, Gelfo Francesca, Caltagirone Carlo, Bernardini Sergio, Angelucci Francesco, Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration, Journal of Psychopharmacology, 28, 10, 2014. Crossref

  92. Kishore Bellamkonda K., Ecelbarger Carolyn M., Lithium: a versatile tool for understanding renal physiology, American Journal of Physiology-Renal Physiology, 304, 9, 2013. Crossref

  93. Young Wise, Review of Lithium Effects on Brain and Blood, Cell Transplantation, 18, 9, 2009. Crossref

  94. Lewin M., Ilina M., Betz J., Masiello K., Hui M., Wilson D.A., Saito M., Developmental Ethanol-Induced Sleep Fragmentation, Behavioral Hyperactivity, Cognitive Impairment and Parvalbumin Cell Loss are Prevented by Lithium Co-treatment, Neuroscience, 369, 2018. Crossref

  95. Frazier Elisabeth A., Bipolar Disorder, in Encyclopedia of Adolescence, 2018. Crossref

  96. Elyasi Leila, Eftekhar-Vaghefi Seyed Hassan, Asadi-Shekaari Majid, Esmaeili-Mahani Saeed, Induction of cross-tolerance between protective effect of morphine and nicotine in 6-hydroxydopamine-induce neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells, International Journal of Neuroscience, 129, 2, 2019. Crossref

  97. Föller Michael, Sopjani Mentor, Koka Saisudha, Gu Shuchen, Mahmud Hasan, Wang Kan, Floride Elisa, Schleicher Erwin, Schulz Eberhard, Münzel Thomas, Lang Florian, Regulation of erythrocyte survival by AMP‐activated protein kinase, The FASEB Journal, 23, 4, 2009. Crossref

  98. Ferrier I. Nicol, Ferrie Lindsey J., Macritchie Karine A., Old drug, new data, Advances in Psychiatric Treatment, 12, 4, 2006. Crossref

  99. Ge Weihao, Jakobsson Eric, Systems Biology Understanding of the Effects of Lithium on Affective and Neurodegenerative Disorders, Frontiers in Neuroscience, 12, 2018. Crossref

  100. Weng Yu-Ting, Chien Ting, Kuan I-I, Chern Yijuang, The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions, Journal of Biomedical Science, 25, 1, 2018. Crossref

  101. Lohse Martin J., Lorenzen Anna, Müller-Oerlinghausen Bruno, Psychopharmaka, in Arzneiverordnungs-Report 2005, 2006. Crossref

  102. Xia Zongqi, Roth Bryan L., Novel Mechanisms of Drug Treatment in Psychiatry, in The Medical Basis of Psychiatry, 2008. Crossref

  103. Ostrova I. V., Grebenchikov O. A., Golubeva N. V., Neuroprotective Effect of Lithium Chloride in Rat Model of Cardiac Arrest, General Reanimatology, 15, 3, 2019. Crossref

  104. Lohse Martin J., Lorenzen Anna, Müller-Oerlinghausen Bruno, Psychopharmaka, in Arzneiverordnungs-Report 2006, 2007. Crossref

  105. Jakobsson Eric, Argüello-Miranda Orlando, Chiu See-Wing, Fazal Zeeshan, Kruczek James, Nunez-Corrales Santiago, Pandit Sagar, Pritchet Laura, Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology, The Journal of Membrane Biology, 250, 6, 2017. Crossref

  106. Rahimi Nastaran, Hassanipour Mahsa, Yarmohammadi Fatemeh, Faghir-Ghanesefat Hedyeh, Pourshadi Nastaran, Bahramnejad Erfan, Dehpour Ahmad Reza, Nitric oxide and glutamate are contributors of anti-seizure activity of rubidium chloride: A comparison with lithium, Neuroscience Letters, 708, 2019. Crossref

  107. Gawryluk Jeremy W., Young L. Trevor, Signal Transduction Pathways in the Pathophysiology of Bipolar Disorder, in Behavioral Neurobiology of Bipolar Disorder and its Treatment, 5, 2010. Crossref

  108. Kotlyarova Anastasiya, Bgatova Nataliya, Popova Tatiana, Letyagin Andrey, Tolstikova Tatiana, Pedder Valery, Cognitive Outcome and Neuroprotective Effect of Lithium on Subchronic Alcohol-induced Brain Damage in Mice, 2019 International Multi-Conference on Engineering, Computer and Information Sciences (SIBIRCON), 2019. Crossref

  109. Ala Moein, Mohammad Jafari Razieh, Nematian Hossein, Ganjedanesh Mohammad Reza, Naderi Asieh, Akbariani Mostafa, Sanatkar Mehdi, Satarian Leila, Aghsaei Fard Masoud, Dehpour Ahmad Reza, Neuroprotective Effect of Intravitreal Single-Dose Lithium Chloride after Optic Nerve Injury in Rats, Current Eye Research, 46, 4, 2021. Crossref

  110. De-Paula Vanessa J., dos Santos Carla Cristine C., Luque Maria Carolina A., Ali Taccyana M., Kalil Jorge E., Forlenza Orestes V., Cunha-Neto Edecio, Acute and chronic lithium treatment increases Wnt/β-catenin transcripts in cortical and hippocampal tissue at therapeutic concentrations in mice, Metabolic Brain Disease, 36, 1, 2021. Crossref

  111. Lithium: Underappreciated and Underused?, Journal of Psychosocial Nursing and Mental Health Services, 45, 8, 2007. Crossref

  112. Saft Carsten, Lauter Thorsten, Kraus Peter H, Przuntek Horst, Andrich Juergen E, Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series, BMC Neurology, 6, 1, 2006. Crossref

  113. Leeds Peter R., Yu Fengshan, Wang Zhifei, Chiu Chi-Tso, Zhang Yumin, Leng Yan, Linares Gabriel R., Chuang De-Maw, A New Avenue for Lithium: Intervention in Traumatic Brain Injury, ACS Chemical Neuroscience, 5, 6, 2014. Crossref

  114. Kaur Kiranpreet, Mirlashari Mohammad Reza, Kvalheim Gunnar, Kjeldsen-Kragh Jens, 3′,4′-Dimethoxyflavone and valproic acid promotes the proliferation of human hematopoietic stem cells, Stem Cell Research & Therapy, 4, 3, 2013. Crossref

  115. Malkesman Oz, Austin Daniel R., Chen Guang, Manji Husseini K., Reverse translational strategies for developing animal models of bipolar disorder, Disease Models & Mechanisms, 2, 5-6, 2009. Crossref

  116. Heinrich Annette, Böer Ulrike, Tzvetkov Mladen, Oetjen Elke, Knepel Willhart, Stimulation by lithium of the interaction between the transcription factor CREB and its co-activator TORC, Bioscience Reports, 29, 2, 2009. Crossref

  117. Lithium: Underappreciated and Underused?, Psychiatric Annals, 37, 9, 2007. Crossref

  118. Pryor Kane O., Storer Kingsley P., Drugs for Neuropsychiatric Disorders, in Pharmacology and Physiology for Anesthesia, 2019. Crossref

  119. Ovcharenko Liliia, Cavalcanti Stefanie L. H., Ruiz Ana C., Garcia Nereyda, Machado-Vieira Rodrigo, Biological Targets Underlying the Antisuicidal Effects of Lithium, Current Behavioral Neuroscience Reports, 7, 3, 2020. Crossref

  120. Makoukji Joelle, Belle Martin, Meffre Delphine, Stassart Ruth, Grenier Julien, Shackleford Ghjuvan'Ghjacumu, Fledrich Robert, Fonte Cosima, Branchu Julien, Goulard Marie, de Waele Catherine, Charbonnier Frédéric, Sereda Michael W., Baulieu Etienne-Emile, Schumacher Michael, Bernard Sophie, Massaad Charbel, Lithium enhances remyelination of peripheral nerves, Proceedings of the National Academy of Sciences, 109, 10, 2012. Crossref

  121. Rao J S, Ertley R N, Lee H-J, DeMar J C, Arnold J T, Rapoport S I, Bazinet R P, n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism, Molecular Psychiatry, 12, 1, 2007. Crossref

  122. Shinohe Atsuko, Hashimoto Kenji, Nakamura Kazuhiko, Tsujii Masatsugu, Iwata Yasuhide, Tsuchiya Kenji J., Sekine Yoshimoto, Suda Shiro, Suzuki Katsuaki, Sugihara Gen-ichi, Matsuzaki Hideo, Minabe Yoshio, Sugiyama Toshiro, Kawai Masayoshi, Iyo Masaomi, Takei Nori, Mori Norio, Increased serum levels of glutamate in adult patients with autism, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 8, 2006. Crossref

  123. Kim Young R., van Meer Maurits P.A., Tejima Emiri, Murata Yoshi, Mandeville Joseph B., Dai George, Chuang De-Maw, Rosen Bruce R., Lo Eng H., Functional MRI of Delayed Chronic Lithium Treatment in Rat Focal Cerebral Ischemia, Stroke, 39, 2, 2008. Crossref

  124. Hashimoto Kenji, Sawa Akira, Iyo Masaomi, Increased Levels of Glutamate in Brains from Patients with Mood Disorders, Biological Psychiatry, 62, 11, 2007. Crossref

  125. Hunsberger Joshua, Austin Daniel R., Henter Ioline D., Chen Guang, The neurotrophic and neuroprotective effects of psychotropic agents, Dialogues in Clinical Neuroscience, 11, 3, 2009. Crossref

  126. Engel S R, Creson T K, Hao Y, Shen Y, Maeng S, Nekrasova T, Landreth G E, Manji H K, Chen G, The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement, Molecular Psychiatry, 14, 4, 2009. Crossref

  127. Fumagalli F, Racagni G, Riva M A, The expanding role of BDNF: a therapeutic target for Alzheimer's disease?, The Pharmacogenomics Journal, 6, 1, 2006. Crossref

  128. Kotlyarova Anastasiya A., Letyagin Andrey Yu., Tolstikova Tatiana G, Rachkovskaya Lybov N., Popova Tatyana V., Comparative Pharmacokinetic Analysis of а Novel Prolonged Release Dosage Form of Lithium Citrate in Mice, 2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\Systems Biology (BGRS\SB), 2018. Crossref

  129. Quiroz Jorge A., Chen Guang, Drevets Wayne C., Henter Ioline D., Manji Husseini K., Mood disorders, in Translational Neuroscience, 2012. Crossref

  130. Sorokina Yu. A., Mosina A. A., Pakhomova Yu. M., Zanozin A. V., Biomedical and Potential Therapeutic Aspects of Lithium Carbonate Use, Psikhiatriya, 20, 2, 2022. Crossref

  131. Arraf Zaher, Khamisy-Farah Rola, Amit Tamar, Youdim Moussa B. H., Farah Raymond, Lithium’s Gene Expression Profile, Relevance to Neuroprotection A cDNA Microarray Study, Cellular and Molecular Neurobiology, 33, 3, 2013. Crossref

  132. Ghanaatfar Fateme, Ghanaatfar Ali, Isapour Parisa, Farokhi Negin, Bozorgniahosseini Seyedehnahal, Javadi Mahshid, Gholami Mina, Ulloa Luis, Coleman‐Fuller Natalie, Motaghinejad Majid, Is lithium neuroprotective? An updated mechanistic illustrated review, Fundamental & Clinical Pharmacology, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain